Resources

Past Presentation

Methamphetamine Use Disorder | July 16, 2020

Date of Presentation: July 16, 2020

Type: Past Presentation  

Audience: Clinical  

Program: Substance Use Disorder  

Keywords: #harm reduction  #Methamphetamine Use Disorder  #methamphetamines  

In this presentation, Dr. Jessica Gregg and Dr. Ximena Levander from Oregon Health & Science University discuss the history, chemical structure and epidemiology of methamphetamine use disorder. They also discuss treatment for methamphetamine use disorder, the current status of pharmacologic research, and the important of a harm reduction approach.

 

 

Recording:

Presented by:

Dr. Ximena Levander, Dr. Jessica Gregg

Ximena A. Levander, MD, is an Addiction Medicine & General Internal Medicine Fellow at Oregon Health & Science University.

Jessica Gregg, MD, PhD, is an Associate Professor of Medicine at Oregon Health and Science University. She received her undergraduate degree from Stanford University, her medical degree from the University of New Mexico, and her doctorate in medical anthropology from Emory University. She is board certified in internal medicine and addiction medicine. At OHSU, Dr. Gregg serves as the Director of the university’s addiction medicine ECHO clinics, as Associate Program Director for OHSU’s addiction medicine fellowship, and as Medical Director of the OHSU HRBR clinic, which provides low-barrier MAT to vulnerable adults. She also provides clinical care on IMPACT, OHSU’s inpatient addiction medical consult service.

Resources Provided:

Date added: July 16, 2020